详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Jiao Xuefeng[1,2,3,4] * ; Li Hailong[1,2,3,4] ; Zeng Linan[1,2,3,4] ; Han Lu[1,2,3,4] ; Yang Huazhen[5,6] ; Hu Yao[5,6] ; Qu Yuanyuan[5,6] ; Chen Wenwen[5,6] ; Sun Yajing[5,6] ; Zhang Wei[5,6,*3] ; Lu Donghao[5,7,8,*2] ; Zhang Lingli[1,2,3,4,9,*1] ;

机构： [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China. [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. [3]NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, NMPA, Chengdu, China. [4]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China. [5]West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China. [6]Medical Big Data Center, Sichuan University, Chengdu, China. [7]Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. [8]Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. [9]Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.

出处：

DOI：

基金：

语种：

PubmedID：

第一作者：

第一作者机构： [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China. [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. [3]NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, NMPA, Chengdu, China. [4]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.

通讯作者：

通讯机构： [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China. [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. [3]NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, NMPA, Chengdu, China. [4]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China. [5]West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China. [6]Medical Big Data Center, Sichuan University, Chengdu, China. [7]Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. [8]Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. [9]Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China. [*1]Evidence-Based Pharmacy Center,West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. [*2]Unit of Integrative Epidemiology, Institute of EnvironmentalMedicine, Karolinska Institutet, Stockholm, Sweden [*3]West China Biomedical Big Data Center,West China Hospital, Sichuan University, Chengdu, Sichuan, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Use of statins and risk of uterine leiomyoma: A cohort study in the UK Biobank

文献详情